Pfizer Divests Its Swine Vaccine Business To Harbin Pharmaceutical Group In China As Condition Of $68 Billion Merger With Wyeth

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.